Nisa Investment Advisors
FDMT icon

Nisa Investment Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History

Nisa Investment Advisors’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.2K Sell
5,501
-250
-4% -$2.44K ﹤0.01% 1696
2026
Q1 		$53.5K Buy
5,751
+2,500
+77% +$21.8K ﹤0.01% 1638
2025
Q4 		$24.4K Sell
3,251
-400
-11% -$4.06K ﹤0.01% 1866
2025
Q3 		$31.7K Buy
3,651
+49
+1% +$293 ﹤0.01% 1792
2025
Q2 		$13.4K Sell
3,602
-208
-5% -$731 ﹤0.01% 2127
2025
Q1 		$12.3K Sell
3,810
-40,069
-91% -$189K ﹤0.01% 2047
2024
Q4 		$244K Sell
43,879
-890
-2% -$6.98K ﹤0.01% 1234
2024
Q3 		$484K Sell
44,769
-51,929
-54% -$862K ﹤0.01% 1051
2024
Q2 		$2.03M Buy
96,698
+95,041
+5,736% +$2.38M 0.01% 695
2024
Q1 		$52.8K Buy
1,657
+37
+2% +$944 ﹤0.01% 1637
2023
Q4 		$32.8K Sell
1,620
-250
-13% -$3.29K ﹤0.01% 1732
2023
Q3 		$23.8K Sell
1,870
-12
-0.6% -$201 ﹤0.01% 1963
2023
Q2 		$34K Buy
1,882
+682
+57% +$12.6K ﹤0.01% 1886
2023
Q1 		$21K Sell
1,200
-21
-2% -$408 ﹤0.01% 1992
2022
Q4 		$27K Buy
1,221
+21
+2% +$324 ﹤0.01% 1964
2022
Q3 		$10K Buy
+1,200
New +$10.9K ﹤0.01% 2183
2022
Q2 		– Sell
-16,100
Closed -$243K – 2414
2022
Q1 		$243K Buy
+16,100
New +$253K ﹤0.01% 1303

Other funds holding FDMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Nisa Investment Advisors's FDMT Position: Q2 2026 in Review

Nisa Investment Advisors reduced its 4D Molecular Therapeutics (FDMT) stake by 4.3% in Q2 2026, selling an estimated $2.44K and leaving 5,501 shares worth $73.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

Nisa Investment Advisors first reported a position in FDMT in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.03M in Q2 2024. 54 funds tracked by Wall St. Rank hold FDMT as of Q2 2026.

  • Nisa Investment Advisors held 5,501 shares of 4D Molecular Therapeutics worth $73.2K as of Q2 2026.
  • Nisa Investment Advisors sold 250 4D Molecular Therapeutics shares in Q2 2026, an estimated $2.44K.
  • 4D Molecular Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1696 holding.
  • Nisa Investment Advisors first reported a position in 4D Molecular Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Nisa Investment Advisors's 4D Molecular Therapeutics position peaked at $2.03M in Q2 2024.
  • 54 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.